vs
Organogenesis Holdings Inc.（ORGO）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是STURM RUGER & CO INC的1.5倍（$225.6M vs $151.1M），Organogenesis Holdings Inc.同比增速更快（78.1% vs 3.6%），Organogenesis Holdings Inc.自由现金流更多（$34.8M vs $12.3M），过去两年Organogenesis Holdings Inc.的营收复合增速更高（43.2% vs 5.1%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
ORGO vs RGR — 直观对比
营收规模更大
ORGO
是对方的1.5倍
$151.1M
营收增速更快
ORGO
高出74.5%
3.6%
自由现金流更多
ORGO
多$22.4M
$12.3M
两年增速更快
ORGO
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $151.1M |
| 净利润 | $43.7M | — |
| 毛利率 | — | 17.8% |
| 营业利润率 | 28.1% | 2.3% |
| 净利率 | 19.4% | — |
| 营收同比 | 78.1% | 3.6% |
| 净利润同比 | 469.5% | — |
| 每股收益（稀释后） | $0.31 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGORGR
| Q4 25 | $225.6M | $151.1M | ||
| Q3 25 | $150.9M | $126.8M | ||
| Q2 25 | $101.0M | $132.5M | ||
| Q1 25 | $86.7M | $135.7M | ||
| Q4 24 | $126.7M | $145.8M | ||
| Q3 24 | $115.2M | $122.3M | ||
| Q2 24 | $130.2M | $130.8M | ||
| Q1 24 | $110.0M | $136.8M |
净利润ORGORGR
| Q4 25 | $43.7M | — | ||
| Q3 25 | $21.6M | $1.6M | ||
| Q2 25 | $-9.4M | $-17.2M | ||
| Q1 25 | $-18.8M | $7.8M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $12.3M | $4.7M | ||
| Q2 24 | $-17.0M | $8.3M | ||
| Q1 24 | $-2.1M | $7.1M |
毛利率ORGORGR
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | 72.6% | 22.0% | ||
| Q4 24 | 75.5% | 22.8% | ||
| Q3 24 | 76.7% | 18.5% | ||
| Q2 24 | 77.6% | 22.3% | ||
| Q1 24 | 73.9% | 21.5% |
营业利润率ORGORGR
| Q4 25 | 28.1% | 2.3% | ||
| Q3 25 | 13.7% | -2.7% | ||
| Q2 25 | -12.5% | -15.6% | ||
| Q1 25 | -30.9% | 6.2% | ||
| Q4 24 | 8.1% | 7.8% | ||
| Q3 24 | 5.4% | 3.1% | ||
| Q2 24 | -10.7% | 6.9% | ||
| Q1 24 | -3.5% | 5.5% |
净利率ORGORGR
| Q4 25 | 19.4% | — | ||
| Q3 25 | 14.3% | 1.2% | ||
| Q2 25 | -9.3% | -13.0% | ||
| Q1 25 | -21.7% | 5.7% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 10.7% | 3.9% | ||
| Q2 24 | -13.1% | 6.3% | ||
| Q1 24 | -1.9% | 5.2% |
每股收益（稀释后）ORGORGR
| Q4 25 | $0.31 | $0.22 | ||
| Q3 25 | $0.11 | $0.10 | ||
| Q2 25 | $-0.10 | $-1.05 | ||
| Q1 25 | $-0.17 | $0.46 | ||
| Q4 24 | $0.05 | $0.62 | ||
| Q3 24 | $0.09 | $0.28 | ||
| Q2 24 | $-0.13 | $0.47 | ||
| Q1 24 | $-0.02 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $300.1M | $283.8M |
| 总资产 | $598.7M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGORGR
| Q4 25 | $93.7M | $92.5M | ||
| Q3 25 | $63.7M | $80.8M | ||
| Q2 25 | $73.1M | $101.4M | ||
| Q1 25 | $110.0M | $108.3M | ||
| Q4 24 | $135.6M | $105.5M | ||
| Q3 24 | $94.3M | $96.0M | ||
| Q2 24 | $89.9M | $105.6M | ||
| Q1 24 | $88.6M | $115.3M |
总债务ORGORGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | — |
股东权益ORGORGR
| Q4 25 | $300.1M | $283.8M | ||
| Q3 25 | $255.1M | $279.6M | ||
| Q2 25 | $233.2M | $289.3M | ||
| Q1 25 | $242.9M | $321.5M | ||
| Q4 24 | $262.9M | $319.6M | ||
| Q3 24 | $278.5M | $314.9M | ||
| Q2 24 | $263.5M | $321.5M | ||
| Q1 24 | $278.0M | $332.0M |
总资产ORGORGR
| Q4 25 | $598.7M | $342.0M | ||
| Q3 25 | $509.8M | $342.3M | ||
| Q2 25 | $461.1M | $349.5M | ||
| Q1 25 | $467.4M | $379.0M | ||
| Q4 24 | $497.9M | $384.0M | ||
| Q3 24 | $446.3M | $373.5M | ||
| Q2 24 | $443.2M | $376.7M | ||
| Q1 24 | $458.5M | $385.0M |
负债/权益比ORGORGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.4M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | $12.3M |
| 自由现金流率自由现金流/营收 | 15.4% | 8.2% |
| 资本支出强度资本支出/营收 | 2.1% | 2.1% |
| 现金转化率经营现金流/净利润 | 0.90× | — |
| 过去12个月自由现金流最近4个季度 | $-24.5M | $38.5M |
8季度趋势，按日历期对齐
经营现金流ORGORGR
| Q4 25 | $39.4M | $15.5M | ||
| Q3 25 | $3.1M | $12.9M | ||
| Q2 25 | $-32.9M | $14.7M | ||
| Q1 25 | $-19.9M | $11.1M | ||
| Q4 24 | $10.9M | $20.0M | ||
| Q3 24 | $8.7M | $9.4M | ||
| Q2 24 | $4.7M | $18.7M | ||
| Q1 24 | $-10.2M | $7.3M |
自由现金流ORGORGR
| Q4 25 | $34.8M | $12.3M | ||
| Q3 25 | $844.0K | $7.0M | ||
| Q2 25 | $-36.5M | $9.1M | ||
| Q1 25 | $-23.6M | $10.0M | ||
| Q4 24 | $7.6M | $16.4M | ||
| Q3 24 | $6.1M | $2.6M | ||
| Q2 24 | $2.9M | $10.1M | ||
| Q1 24 | $-12.4M | $5.6M |
自由现金流率ORGORGR
| Q4 25 | 15.4% | 8.2% | ||
| Q3 25 | 0.6% | 5.5% | ||
| Q2 25 | -36.1% | 6.9% | ||
| Q1 25 | -27.2% | 7.4% | ||
| Q4 24 | 6.0% | 11.2% | ||
| Q3 24 | 5.3% | 2.1% | ||
| Q2 24 | 2.2% | 7.7% | ||
| Q1 24 | -11.3% | 4.1% |
资本支出强度ORGORGR
| Q4 25 | 2.1% | 2.1% | ||
| Q3 25 | 1.5% | 4.6% | ||
| Q2 25 | 3.6% | 4.2% | ||
| Q1 25 | 4.2% | 0.8% | ||
| Q4 24 | 2.7% | 2.5% | ||
| Q3 24 | 2.2% | 5.5% | ||
| Q2 24 | 1.4% | 6.6% | ||
| Q1 24 | 2.0% | 1.3% |
现金转化率ORGORGR
| Q4 25 | 0.90× | — | ||
| Q3 25 | 0.14× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
